36 results on '"Hayden, Kathleen M."'
Search Results
2. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging.
- Author
-
Hayden KM, McEvoy JM, Linnertz C, Attix D, Kuchibhatla M, Saunders AM, Lutz MW, Welsh-Bohmer KA, Roses AD, and Chiba-Falek O
- Subjects
- Aged, Aged, 80 and over, Apolipoproteins E genetics, Female, Genotype, Humans, Male, Middle Aged, Mitochondrial Precursor Protein Import Complex Proteins, Neuropsychological Tests, Aging genetics, Cognition Disorders genetics, Genetic Predisposition to Disease genetics, Membrane Transport Proteins genetics, Polymorphism, Genetic genetics
- Abstract
Introduction: A highly polymorphic T homopolymer was recently found to be associated with late-onset Alzheimer's disease risk and age of onset., Objective: To explore the effects of the polymorphic polyT tract (rs10524523, referred as '523') on cognitive performance in cognitively healthy elderly individuals., Methods: One hundred eighty-one participants were recruited from local independent-living retirement communities. Informed consent was obtained, and participants completed demographic questionnaires, a conventional paper-and-pencil neuropsychological battery, and the computerized Cambridge Neuropsychological Test Automated Battery (CANTAB). Saliva samples were collected for determination of the TOMM40 '523' (S, L, VL) and the apolipoprotein E (APOE) (ɛ2, 3, 4) genotypes. From the initial sample of 181 individuals, 127 were eligible for the association analysis. Participants were divided into three groups based on '523' genotypes (S/S, S/L-S/VL, and L/L-L/VL-VL/VL). Generalized linear models were used to evaluate the association between the '523' genotypes and neuropsychological test performance. Analyses were adjusted for age, sex, education, depression, and APOE ɛ4 status. A planned subanalysis was undertaken to evaluate the association between '523' genotypes and test performance in a sample restricted to APOE ɛ3 homozygotes., Results: The S homozygotes performed better, although not significantly, than the S/L-S/VL and the VL/L-L/VL-VL/VL genotype groups on measures associated with memory (CANTAB Paired Associates Learning, Verbal Recognition Memory free recall) and executive function (CANTAB measures of Intra-Extra Dimensional Set Shift). Follow-up analysis of APOE ɛ3 homozygotes only showed that the S/S group performed significantly better than the S/VL group on measures of episodic memory (CANTAB Paired Associates Learning and Verbal Recognition Memory free recall), attention (CANTAB Rapid Visual Information Processing latency), and executive function (Digit Symbol Substitution). The S/S group performed marginally better than the VL/VL group on Intra-Extra Dimensional Set Shift. None of the associations remained significant after applying a Bonferroni correction for multiple testing., Conclusions: Results suggest important APOE-independent associations between the TOMM40 '523' polymorphism and specific cognitive domains of memory and executive control that are preferentially affected in early-stage Alzheimer's disease., (Copyright © 2012 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
3. Epidemiology of cognitive aging and Alzheimer's disease: contributions of the cache county utah study of memory, health and aging.
- Author
-
Hayden KM and Welsh-Bohmer KA
- Subjects
- Alzheimer Disease physiopathology, Alzheimer Disease psychology, Disease Progression, Female, Humans, Incidence, Life Style, Longitudinal Studies, Male, Neuropsychological Tests, Prevalence, Prodromal Symptoms, Risk Factors, Utah epidemiology, Aging, Alzheimer Disease epidemiology, Cognition Disorders epidemiology, Memory Disorders epidemiology, Residence Characteristics
- Abstract
Epidemiological studies of Alzheimer's disease (AD) provide insights into changing public health trends and their contribution to disease incidence. The current chapter considers how the population-based approach has contributed to our understanding of lifetime exposures that contribute to later disease risk and may act to modify onset of symptoms. We focus on the findings from a recent survey of an exceptionally long-lived population, the Cache County Utah Study of Memory, Health, and Aging. This study is confined to a single geographic population has allowed estimation of the genetic and environmental influences on AD expression across the expected human lifespan of 95+ years. Given the emphasis of this text on the behavioral neurosciences of aging, we highlight within the current chapter the particular contributions of this population-based study to the neuropsychology of aging and AD. We also discuss hypotheses generated from this survey with respect to factors that may either accelerate or delay symptom onset in AD and the conditions that appear to be associated with successful cognitive aging.
- Published
- 2012
- Full Text
- View/download PDF
4. Cognitive decline in the elderly: an analysis of population heterogeneity.
- Author
-
Hayden KM, Reed BR, Manly JJ, Tommet D, Pietrzak RH, Chelune GJ, Yang FM, Revell AJ, Bennett DA, and Jones RN
- Subjects
- Age Factors, Aged, Aged, 80 and over, Cognition physiology, Cognition Disorders ethnology, Cohort Studies, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Prevalence, Time Factors, United States, Aging physiology, Cognition Disorders epidemiology, Cognition Disorders physiopathology
- Abstract
Background: studies of cognitive ageing at the group level suggest that age is associated with cognitive decline; however, there may be individual differences such that not all older adults will experience cognitive decline., Objective: to evaluate patterns of cognitive decline in a cohort of older adults initially free of dementia., Design, Setting and Subjects: elderly Catholic clergy members participating in the Religious Orders Study were followed for up to 15 years. Cognitive performance was assessed annually., Methods: performance on a composite global measure of cognition was analysed using random effects models for baseline performance and change over time. A profile mixture component was used to identify subgroups with different cognitive trajectories over the study period., Results: from a sample of 1,049 participants (mean age 75 years), three subgroups were identified based on the distribution of baseline performance and change over time. The majority (65%) of participants belonged to a slow decline class that did not experience substantial cognitive decline over the observation period [-0.04 baseline total sample standard deviation (SD) units/year]. About 27% experienced moderate decline (-0.19 SD/year), and 8% belonged to a class experiencing rapid decline (-0.57 SD/year). A subsample analysis revealed that when substantial cognitive decline does occur, the magnitude and rate of decline is correlated with neuropathological processes., Conclusions: in this sample, the most common pattern of cognitive decline is extremely slow, perceptible on a time scale measured by decades, not years. While in need of cross validation, these findings suggest that cognitive changes associated with ageing may be minimal and emphasise the importance of understanding the full range of age-related pathologies that may diminish brain function.
- Published
- 2011
- Full Text
- View/download PDF
5. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1.
- Author
-
Mayeux R, Reitz C, Brickman AM, Haan MN, Manly JJ, Glymour MM, Weiss CC, Yaffe K, Middleton L, Hendrie HC, Warren LH, Hayden KM, Welsh-Bohmer KA, Breitner JC, and Morris JC
- Subjects
- Age Factors, Alzheimer Disease complications, Alzheimer Disease epidemiology, Biomarkers cerebrospinal fluid, Cerebrovascular Disorders diagnosis, Cognition Disorders complications, Community Health Planning, Diagnostic and Statistical Manual of Mental Disorders, Humans, Neuropsychological Tests, Aging, Alzheimer Disease diagnosis, Cognition Disorders diagnosis, Diagnostic Techniques and Procedures standards
- Abstract
In this article, the challenges faced by several noted population studies for Alzheimer dementia in operationalizing current clinical diagnostic criteria for Alzheimer's disease (AD) have been reviewed. Differences in case ascertainment, methodological biases, cultural and educational influences on test performance, inclusion of special populations such as underrepresented minorities and the oldest old, and detection of the earliest symptomatic stages of underlying AD have been considered. Classification of Alzheimer dementia may be improved by the incorporation of biomarkers for AD if the sensitivity, specificity, and predictive value of the biomarkers are established and if they are appropriate for epidemiological studies, as may occur should a plasma biomarker be developed. Biomarkers for AD could also facilitate studies of the interactions of various forms of neurodegenerative disorders with cerebrovascular disease, resulting in "mixed dementia"., (Copyright © 2011. Published by Elsevier Inc.)
- Published
- 2011
- Full Text
- View/download PDF
6. Neuropsychological performance in advanced age: influences of demographic factors and Apolipoprotein E: findings from the Cache County Memory Study.
- Author
-
Welsh-Bohmer KA, Ostbye T, Sanders L, Pieper CF, Hayden KM, Tschanz JT, and Norton MC
- Subjects
- Age Factors, Aged, Aged, 80 and over, Female, Humans, Male, Neuropsychological Tests statistics & numerical data, Regression Analysis, Residence Characteristics, Aging genetics, Aging physiology, Aging psychology, Apolipoproteins E genetics, Mental Processes physiology, Neuropsychological Tests standards
- Abstract
The Cache County Study of Memory in Aging (CCMS) is an epidemiological study of Alzheimer's disease (AD), mild cognitive disorders, and aging in a population of exceptionally long-lived individuals (7th to 11th decade). Observation of population members without dementia provides an opportunity for establishing the range of normal neurocognitive performance in a representative sample of the very old. We examined neurocognitive performance of the normal participants undergoing full clinical evaluations (n = 507) and we tested the potential modifying effects of apolipoprotein E (APOE) genotype, a known genetic risk factor for the later development of AD. The results indicate that advanced age and low education are related to lower test scores across nearly all of the neurocognitive measures. Gender and APOE epsilon4 both had negligible and inconsistent influences, affecting only isolated measures of memory and expressive speech (in case of gender). The gender and APOE effects disappeared once age and education were controlled. The study of this exceptionally long-lived population provides useful normative information regarding the broad range of "normal" cognition seen in advanced age. Among elderly without dementia or other cognitive impairment, APOE does not appear to exert any major effects on cognition once other demographic influences are controlled.
- Published
- 2009
- Full Text
- View/download PDF
7. Neighborhood segregation and cognitive change: Multi‐Ethnic Study of Atherosclerosis
- Author
-
Besser, Lilah M, Meyer, Oanh L, Jones, Miranda R, Tran, Duyen, Booker, Michaela, Mitsova, Diana, Peterson, Rachel, Galvin, James E, Bateman, James R, Hayden, Kathleen M, and Hughes, Timothy M
- Subjects
Biomedical and Clinical Sciences ,Biological Psychology ,Clinical Sciences ,Neurosciences ,Psychology ,Minority Health ,Health Disparities ,Clinical Research ,Aging ,Behavioral and Social Science ,Social Determinants of Health ,Basic Behavioral and Social Science ,Atherosclerosis ,Aged ,Humans ,Black or African American ,Ethnicity ,Hispanic or Latino ,White ,Asian ,Residential Segregation ,cognition ,cognitive decline ,community ,ethnicity ,longitudinal ,neighborhood ,processing speed ,race ,racial ,segregation ,social determinants of health ,structural determinants ,Geriatrics ,Clinical sciences ,Biological psychology - Abstract
IntroductionWe investigated associations between neighborhood racial/ethnic segregation and cognitive change.MethodsWe used data (n = 1712) from the Multi-Ethnic Study of Atherosclerosis. Racial/ethnic segregation was assessed using Getis-Ord (Gi*) z-scores based on American Community Survey Census tract data (higher Gi* = greater spatial clustering of participant's race/ethnicity). Global cognition and processing speed were assessed twice, 6 years apart. Adjusted multilevel linear regression tested associations between Gi* z-scores and cognition. Effect modification by race/ethnicity, income, education, neighborhood socioeconomic status, and neighborhood social support was tested.ResultsParticipants were on average 67 years old; 43% were White, 11% Chinese, 29% African American/Black, 17% Hispanic; 40% had high neighborhood segregation (Gi* > 1.96). African American/Black participants with greater neighborhood segregation had greater processing speed decline in stratified analyses, but no interactions were significant.DiscussionSegregation was associated with greater processing speed declines among African American/Black participants. Additional follow-ups and comprehensive cognitive batteries may further elucidate these findings.HighlightsA study of neighborhood racial/ethnic segregation and change in cognition. Study was based on a racially and geographically diverse, population-based cohort of older adults. Racial/ethnic segregation (clustering) was measured by the Getis-ord (Gi*) statistic. We saw faster processing speed decline among Black individuals in segregated neighborhoods.
- Published
- 2023
8. Plasma proteins related to inflammatory diet predict future cognitive impairment
- Author
-
Duggan, Michael R, Butler, Lauren, Peng, Zhongsheng, Daya, Gulzar N, Moghekar, Abhay, An, Yang, Rapp, Stephen R, Hayden, Kathleen M, Shadyab, Aladdin H, Natale, Ginny, Liu, Longjian, Snetselaar, Linda, Moaddel, Ruin, Rebholz, Casey M, Sullivan, Kevin, Ballantyne, Christie M, Resnick, Susan M, Ferrucci, Luigi, and Walker, Keenan A
- Subjects
Biomedical and Clinical Sciences ,Nutrition and Dietetics ,Neurosciences ,Neurodegenerative ,Dementia ,Acquired Cognitive Impairment ,Brain Disorders ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Nutrition ,Aging ,Alzheimer's Disease ,Clinical Research ,Prevention ,2.1 Biological and endogenous factors ,Aetiology ,Detection ,screening and diagnosis ,4.1 Discovery and preclinical testing of markers and technologies ,Neurological ,Inflammatory and immune system ,Humans ,Female ,Aged ,Proteomics ,Alzheimer Disease ,Cognitive Dysfunction ,Diet ,Blood Proteins ,Biomarkers ,tau Proteins ,Amyloid beta-Peptides ,Antigens ,Neoplasm ,Cell Adhesion Molecules ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Psychiatry ,Clinical sciences ,Biological psychology ,Clinical and health psychology - Abstract
Dysregulation of the immune system and dietary patterns that increase inflammation can increase the risk for cognitive decline, but the mechanisms by which inflammatory nutritional habits may affect the development of cognitive impairment in aging are not well understood. To determine whether plasma proteins linked to inflammatory diet predict future cognitive impairment, we applied high-throughput proteomic assays to plasma samples from a subset (n = 1528) of Women's Health Initiative Memory Study (WHIMS) participants (mean [SD] baseline age, 71.3 [SD 3.8] years). Results provide insights into how inflammatory nutritional patterns are associated with an immune-related proteome and identify a group of proteins (CXCL10, CCL3, HGF, OPG, CDCP1, NFATC3, ITGA11) related to future cognitive impairment over a 14-year follow-up period. Several of these inflammatory diet proteins were also associated with dementia risk across two external cohorts (ARIC, ESTHER), correlated with plasma biomarkers of Alzheimer's disease (AD) pathology (Aβ42/40) and/or neurodegeneration (NfL), and related to an MRI-defined index of neurodegenerative brain atrophy in a separate cohort (BLSA). In addition to evaluating their biological relevance, assessing their potential role in AD, and characterizing their immune-tissue/cell-specific expression, we leveraged published RNA-seq results to examine how the in vitro regulation of genes encoding these candidate proteins might be altered in response to an immune challenge. Our findings indicate how dietary patterns with higher inflammatory potential relate to plasma levels of immunologically relevant proteins and highlight the molecular mediators which predict subsequent risk for age-related cognitive impairment.
- Published
- 2023
9. Association of Epigenetic Age Acceleration with Incident Mild Cognitive Impairment and Dementia Among Older Women
- Author
-
Shadyab, Aladdin H, McEvoy, Linda K, Horvath, Steve, Whitsel, Eric A, Rapp, Stephen R, Espeland, Mark A, Resnick, Susan M, Manson, JoAnn E, Chen, Jiu-Chiuan, Chen, Brian H, Li, Wenjun, Hayden, Kathleen M, Bao, Wei, Kusters, Cynthia DJ, and LaCroix, Andrea Z
- Subjects
Alzheimer's Disease ,Heart Disease ,Dementia ,Prevention ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Cardiovascular ,Aging ,Clinical Research ,Neurodegenerative ,Brain Disorders ,Acquired Cognitive Impairment ,Neurological ,Acceleration ,Aged ,Cognitive Dysfunction ,Cohort Studies ,Epigenesis ,Genetic ,Female ,Humans ,Prospective Studies ,Alzheimer's disease ,Biomarker ,Cognitive aging ,Alzheimer’s disease ,Clinical Sciences ,Gerontology - Abstract
BackgroundEpigenetic age acceleration (AgeAccel), which indicates faster biological aging relative to chronological age, has been associated with lower cognitive function. However, the association of AgeAccel with mild cognitive impairment (MCI) or dementia is not well-understood. We examined associations of 4 AgeAccel measures with incident MCI and dementia.MethodsThis prospective analysis included 578 older women from the Women's Health Initiative Memory Study selected for a case-cohort study of coronary heart disease (CHD). Women were free of CHD and cognitive impairment at baseline. Associations of AgeAccel measures (intrinsic AgeAccel [IEAA], extrinsic AgeAccel [EEAA], AgeAccelPheno, and AgeAccelGrim) with risks for incident adjudicated diagnoses of MCI and dementia overall and stratified by incident CHD status were evaluated.ResultsIEAA was not significantly associated with MCI (HR, 1.23; 95% CI, 0.99-1.53), dementia (HR, 1.10; 95% CI, 0.88-1.38), or cognitive impairment (HR, 1.18; 95% CI, 0.99-1.40). In stratified analysis by incident CHD status, there was a 39% (HR, 1.39; 95% CI, 1.07-1.81) significantly higher risk of MCI for every 5-year increase in IEAA among women who developed CHD during follow-up. Other AgeAccel measures were not significantly associated with MCI or dementia.ConclusionsIEAA was not significantly associated with cognitive impairment overall but was associated with impairment among women who developed CHD. Larger studies designed to examine associations of AgeAccel with cognitive impairment are needed, including exploration of whether associations are stronger in the setting of underlying vascular pathologies.
- Published
- 2022
10. Clonal Hematopoiesis Is Associated With Higher Risk of Stroke
- Author
-
Bhattacharya, Romit, Zekavat, Seyedeh M, Haessler, Jeffrey, Fornage, Myriam, Raffield, Laura, Uddin, Mesbah, Bick, Alexander G, Niroula, Abhishek, Yu, Bing, Gibson, Christopher, Griffin, Gabriel, Morrison, Alanna C, Psaty, Bruce M, Longstreth, William T, Bis, Joshua C, Rich, Stephen S, Rotter, Jerome I, Tracy, Russell P, Correa, Adolfo, Seshadri, Sudha, Johnson, Andrew, Collins, Jason M, Hayden, Kathleen M, Madsen, Tracy E, Ballantyne, Christie M, Jaiswal, Siddhartha, Ebert, Benjamin L, Kooperberg, Charles, Manson, JoAnn E, Whitsel, Eric A, Program, NHLBI Trans-Omics for Precision Medicine, Natarajan, Pradeep, and Reiner, Alexander P
- Subjects
Epidemiology ,Health Sciences ,Human Genome ,Prevention ,Brain Disorders ,Neurosciences ,Stroke ,Genetics ,Aging ,Good Health and Well Being ,Adult ,Aged ,Aged ,80 and over ,Clonal Hematopoiesis ,DNA Methyltransferase 3A ,DNA-Binding Proteins ,Dioxygenases ,Female ,Hemorrhagic Stroke ,Humans ,Incidence ,Ischemic Stroke ,Male ,Middle Aged ,Prevalence ,Repressor Proteins ,Risk ,NHLBI Trans-Omics for Precision Medicine Program ,brain ischemia ,cardiovascular diseases ,clonal hematopoiesis ,humans ,prospective studies ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Neurology & Neurosurgery ,Clinical sciences ,Allied health and rehabilitation science - Abstract
Background and purposeClonal hematopoiesis of indeterminate potential (CHIP) is a novel age-related risk factor for cardiovascular disease-related morbidity and mortality. The association of CHIP with risk of incident ischemic stroke was reported previously in an exploratory analysis including a small number of incident stroke cases without replication and lack of stroke subphenotyping. The purpose of this study was to discover whether CHIP is a risk factor for ischemic or hemorrhagic stroke.MethodsWe utilized plasma genome sequence data of blood DNA to identify CHIP in 78 752 individuals from 8 prospective cohorts and biobanks. We then assessed the association of CHIP and commonly mutated individual CHIP driver genes (DNMT3A, TET2, and ASXL1) with any stroke, ischemic stroke, and hemorrhagic stroke.ResultsCHIP was associated with an increased risk of total stroke (hazard ratio, 1.14 [95% CI, 1.03-1.27]; P=0.01) after adjustment for age, sex, and race. We observed associations with CHIP with risk of hemorrhagic stroke (hazard ratio, 1.24 [95% CI, 1.01-1.51]; P=0.04) and with small vessel ischemic stroke subtypes. In gene-specific association results, TET2 showed the strongest association with total stroke and ischemic stroke, whereas DMNT3A and TET2 were each associated with increased risk of hemorrhagic stroke.ConclusionsCHIP is associated with an increased risk of stroke, particularly with hemorrhagic and small vessel ischemic stroke. Future studies clarifying the relationship between CHIP and subtypes of stroke are needed.
- Published
- 2022
11. Adherence to MIND Diet, Genetic Susceptibility, and Incident Dementia in Three US Cohorts
- Author
-
Vu, Thanh Huyen T, Beck, Todd, Bennett, David A, Schneider, Julie A, Hayden, Kathleen M, Shadyab, Aladdin H, Rajan, Kumar B, Morris, Martha Clare, and Cornelis, Marilyn C
- Subjects
Health Services and Systems ,Health Sciences ,Neurodegenerative ,Behavioral and Social Science ,Neurosciences ,Dementia ,Genetics ,Aging ,Nutrition ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Acquired Cognitive Impairment ,Prevention ,Alzheimer's Disease ,Clinical Research ,Brain Disorders ,Neurological ,Alzheimer Disease ,Diet ,Mediterranean ,Dietary Approaches To Stop Hypertension ,Female ,Genetic Predisposition to Disease ,Genome-Wide Association Study ,Humans ,Male ,Prospective Studies ,diet pattern ,dementia ,genotype ,interaction ,Food Sciences ,Nutrition and Dietetics ,Clinical sciences ,Nutrition and dietetics ,Public health - Abstract
Adherence to Mediterranean-DASH Diet Intervention for Neurodegenerative Delay (MIND) may lower the risk of dementia by impacting immunity and cholesterol, which are pathways also implicated by genome-wide association studies of Alzheimer’s Dementia (AD). We examined whether adherence to the MIND diet could modify the association of genetic risk for AD with incident dementia. We used three ongoing US cohorts: Chicago Health and Aging Project (CHAP, n = 2449), Rush Memory and Aging Project (MAP, n = 725), and Women’s Health Initiative Memory Study (WHIMS, n = 5308). Diagnosis of dementia was based on clinical neurological examination and standardized criteria. Repeated measures of global cognitive function were available in MAP and CHAP. Self-reported adherence to MIND was estimated using food-frequency questionnaires. Global and pathway-specific genetic scores (GS) for AD were derived. Cox proportional hazard, logistic regression, and mixed models were used to examine associations of MIND, GS, and GS-MIND interactions with incident dementia and cognitive decline. Higher adherence to MIND and lower GS were associated with a lower risk of dementia in MAP and WHIMS and a slower rate of cognitive decline in MAP (p < 0.05). MIND or GS were not associated with incident dementia or cognitive decline in CHAP. No gene−diet interaction was replicated across cohorts. Genetic risk and MIND adherence are independently associated with dementia among older US men and women.
- Published
- 2022
12. Diet quality indices and risk of metabolic syndrome among postmenopausal women of Mexican ethnic descent in the Women’s Health Initiative Observational Study
- Author
-
Santiago-Torres, Margarita, Shi, Zaixing, Tinker, Lesley F, Lampe, Johanna W, Allison, Matthew A, Barrington, Wendy, Crane, Tracy E, Garcia, David O, Hayden, Kathleen M, Isasi, Carmen R, Valdiviezo-Schlomp, Carolina I, Martin, Lisa W, and Neuhouser, Marian L
- Subjects
Reproductive Medicine ,Biomedical and Clinical Sciences ,Nutrition and Dietetics ,Nutrition ,Aging ,Diabetes ,Prevention ,Cardiovascular ,Clinical Research ,Metabolic and endocrine ,DASH ,HEI ,MDS ,Mediterranean Diet Score ,MexD score ,WHI ,aMED ,diet quality indices ,dietary patterns ,metabolic syndrome ,traditional Mexican diet ,women of Mexican descent ,Medical biochemistry and metabolomics ,Nutrition and dietetics - Abstract
BackgroundThe prevalence of metabolic syndrome is higher among minority populations, including individuals of Mexican ethnic descent. Whether alignment to healthy dietary patterns is associated with lower risk of metabolic syndrome in this population is largely unknown.ObjectiveTo prospectively evaluate the associations between a priori diet quality scores and risk of metabolic syndrome and its components among postmenopausal women of Mexican ethnic descent.MethodsA total of 334 women of Mexican ethnic descent who participated in the Women's Health Initiative (WHI) observational study without metabolic syndrome or diabetes at baseline (1993-1998) were included. Baseline diets were scored with the Alternate Mediterranean Diet (aMED), the Dietary Approaches to Stop Hypertension (DASH), the Healthy Eating Index (HEI-2010), the Mediterranean Diet Score (MDS), and the traditional Mexican Diet (MexD) score. Multivariable linear and logistic regression models were used to test the associations between baseline diet quality and risk of metabolic syndrome and its individual components at follow-up (2012-2013).ResultsApproximately 16% of women met the criteria for metabolic syndrome at follow-up. None of the diet quality indices were associated with risk of metabolic syndrome. However, higher vs lower DASH scores were associated with lower waist circumference (85.2 vs 88.0 cm) and glucose concentrations (90.0 vs 95.1 mg/dL), and higher HDL cholesterol (62.6 vs 59.0 mg/dL), while higher vs lower HEI-2010 scores were associated with lower waist circumference (83.9 vs 88.1 cm), triglycerides (103 vs 117 mg/dL) and glucose concentrations (89.5 vs 94.4 mg/dL), and higher HDL cholesterol levels (63.9 vs 58.5 mg/dL).ConclusionsDiet quality was not associated with risk of metabolic syndrome in this population. However, the results suggest that alignment to DASH and HEI-2010 recommendations may be beneficial for reducing some individual components of metabolic syndrome among postmenopausal women of Mexican descent.
- Published
- 2020
13. Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta‐analysis consisting 2.8 million adults with 57 294 cases of dementia
- Author
-
Lee, Crystal ManYing, Woodward, Mark, Batty, G David, Beiser, Alexa S, Bell, Steven, Berr, Claudine, Bjertness, Espen, Chalmers, John, Clarke, Robert, Dartigues, Jean‐Francois, Davis‐Plourde, Kendra, Debette, Stéphanie, Di Angelantonio, Emanuele, Feart, Catherine, Frikke‐Schmidt, Ruth, Gregson, John, Haan, Mary N, Hassing, Linda B, Hayden, Kathleen M, Hoevenaar‐Blom, Marieke P, Kaprio, Jaakko, Kivimaki, Mika, Lappas, Georgios, Larson, Eric B, LeBlanc, Erin S, Lee, Anne, Lui, Li‐Yung, van Charante, Eric P Moll, Ninomiya, Toshiharu, Nordestgaard, Liv Tybjærg, Ohara, Tomoyuki, Ohkuma, Toshiaki, Palviainen, Teemu, Peres, Karine, Peters, Ruth, Qizilbash, Nawab, Richard, Edo, Rosengren, Annika, Seshadri, Sudha, Shipley, Martin, Singh‐Manoux, Archana, Strand, Bjorn Heine, Gool, Willem A, Vuoksimaa, Eero, Yaffe, Kristine, and Huxley, Rachel R
- Subjects
Biomedical and Clinical Sciences ,Nutrition and Dietetics ,Health Sciences ,Neurosciences ,Dementia ,Acquired Cognitive Impairment ,Clinical Research ,Nutrition ,Neurodegenerative ,Rare Diseases ,Brain Disorders ,Prevention ,Aging ,Obesity ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,2.1 Biological and endogenous factors ,Aetiology ,Neurological ,Cardiovascular ,Adult ,Aged ,Anthropometry ,Body Mass Index ,Body Size ,Body Weight ,Dementia ,Vascular ,Female ,Humans ,Male ,Middle Aged ,Risk Factors ,Thinness ,Waist Circumference ,Weight Gain ,Weight Loss ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Endocrinology & Metabolism ,Biomedical and clinical sciences ,Health sciences ,Psychology - Abstract
Uncertainty exists regarding the relation of body size and weight change with dementia risk. As populations continue to age and the global obesity epidemic shows no sign of waning, reliable quantification of such associations is important. We examined the relationship of body mass index, waist circumference, and annual percent weight change with risk of dementia and its subtypes by pooling data from 19 prospective cohort studies and four clinical trials using meta-analysis. Compared with body mass index-defined lower-normal weight (18.5-22.4 kg/m2 ), the risk of all-cause dementia was higher among underweight individuals but lower among those with upper-normal (22.5-24.9 kg/m2 ) levels. Obesity was associated with higher risk in vascular dementia. Similarly, relative to the lowest fifth of waist circumference, those in the highest fifth had nonsignificant higher vascular dementia risk. Weight loss was associated with higher all-cause dementia risk relative to weight maintenance. Weight gain was weakly associated with higher vascular dementia risk. The relationship between body size, weight change, and dementia is complex and exhibits non-linear associations depending on dementia subtype under scrutiny. Weight loss was associated with an elevated risk most likely due to reverse causality and/or pathophysiological changes in the brain, although the latter remains speculative.
- Published
- 2020
14. Cognitive resilience among APOE ε4 carriers in the oldest old
- Author
-
Hayden, Kathleen M, Gaussoin, Sarah A, Hunter, Jaimie C, Manson, JoAnn E, Sachs, Bonnie C, Shadyab, Aladdin H, Tindle, Hilary A, Mossavar‐Rahmani, Yasmin, Mozhui, Khyobeni, Snively, Beverly M, Rapp, Stephen R, and Resnick, Susan M
- Subjects
Health Services and Systems ,Health Sciences ,Aging ,Clinical Trials and Supportive Activities ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Brain Disorders ,Alzheimer's Disease ,Neurodegenerative ,Acquired Cognitive Impairment ,Prevention ,Clinical Research ,Cardiovascular ,Behavioral and Social Science ,Dementia ,Aged ,Aged ,80 and over ,Apolipoprotein E4 ,Cholesterol ,Cognition ,Cognition Disorders ,Female ,Health Status ,Humans ,Logistic Models ,Male ,Middle Aged ,Neuropsychological Tests ,Odds Ratio ,Resilience ,Psychological ,Risk Factors ,APOE epsilon ,cognitive resilience ,mild cognitive impairment ,oldest old ,probable dementia ,APOE ε ,Clinical Sciences ,Psychology ,Cognitive Sciences ,Geriatrics ,Clinical sciences ,Health services and systems ,Clinical and health psychology - Abstract
ObjectivesRelatively few APOE ε4+ carriers survive to old age (age 80+) without cognitive impairment (CI); thus, little is known about distinguishing characteristics of resilient APOE ε4+ carriers. Herein, we describe the sociodemographic characteristics of a large sample of resilient APOE ε4+ women from the Women's Health Initiative Memory Study (WHIMS) and compare them to noncarriers and APOE ε4+ women who developed CI before age 80.MethodsWomen were recruited for clinical trials evaluating postmenopausal hormone therapy and incidence of dementia. During posttrial follow-up, cognitive status was adjudicated annually. Among 5716 women, we compared groups by APOE ε4 status using logistic regression, covarying for treatment, demographics, lifestyle, cardiovascular and physical function, well-being, and self-rated general health.ResultsAmong 557 APOE ε4+ women, those who survived to age 80+ without CI had higher baseline self-rated general health (odds ratio [OR]: 1.02; 95% confidence interval [CI], 1.01-1.04) and cognitive scores (OR: 1.18; 95% CI, 1.12-1.25) than those who did not reach age 80 without CI. Baseline high total cholesterol and low-density lipoprotein (LDL) levels were similar across APOE ε4+ groups but were higher compared with APOE ε4- women. Among women who survived to 80+ without CI, more APOE ε4+ women had a history of high total cholesterol (P = .003) and LDL cholesterol (OR: 1.01; 95% CI, 1.00-1.01). There were no differences in hypertension, diabetes, or other vascular risk factors in APOE ε4+ women compared with noncarriers.ConclusionsResults highlight the importance of baseline cognitive function and general health for late-life cognition among ε4+ women.
- Published
- 2019
15. Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics
- Author
-
Uddin, Md Mesbah, Zhou, Ying, Bick, Alexander G., Burugula, Bala Bharathi, Jaiswal, Siddhartha, Desai, Pinkal, Honigberg, Michael C., Love, Shelly-Ann, Barac, Ana, Hayden, Kathleen M., Manson, JoAnn E., Whitsel, Eric A., Kooperberg, Charles, Natarajan, Pradeep, Reiner, Alexander P., and Kitzman, Jacob O.
- Published
- 2022
- Full Text
- View/download PDF
16. General and domain‐specific cognitive reserve, mild cognitive impairment, and dementia risk in older women
- Author
-
Petkus, Andrew J, Resnick, Susan M, Rapp, Stephen R, Espeland, Mark A, Gatz, Margaret, Widaman, Keith F, Wang, Xinhui, Younan, Diana, Casanova, Ramon, Chui, Helena, Barnard, Ryan T, Gaussoin, Sarah, Goveas, Joseph S, Hayden, Kathleen M, Henderson, Victor W, Sachs, Bonnie C, Saldana, Santiago, Shadyab, Aladdin H, Shumaker, Sally A, and Chen, Jiu‐Chiuan
- Subjects
Biological Psychology ,Psychology ,Behavioral and Social Science ,Aging ,Brain Disorders ,Dementia ,Clinical Research ,Mental Health ,Neurodegenerative ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Neurosciences ,Acquired Cognitive Impairment ,Alzheimer's Disease ,Neurological ,Cognitive reserve ,Mild cognitive impairment ,Structural equation modeling ,Clinical sciences ,Biological psychology - Abstract
IntroductionIn a geographically diverse sample of women, we asked whether cognitive reserve (CR) is best viewed as a general or cognitive domain-specific construct and whether some cognitive reserve domains but not others exert protective effects on risk of developing mild cognitive impairment (MCI) or dementia.MethodsEstimates of general and domain-specific CR were derived via variance decomposition in 972 cognitively intact women from the Women's Health Initiative Study of Cognitive Aging and Women's Health Memory Study Magnetic Resonance Imaging. Women were then followed up for 13 years.ResultsGeneral CR was the strongest predictor of reduced risk for both MCI and dementia, compared to domain-specific CR measures. Verbal memory, figural memory, and spatial CR were independently protective of MCI, but only verbal memory was independently associated with reduced risk for dementia.DiscussionCognitive reserve is a heterogenous construct with valid quantitative measures identifiable across different neuropsychological processes associated with MCI and dementia.
- Published
- 2019
17. Trajectories of Relative Performance with 2 Measures of Global Cognitive Function
- Author
-
Espeland, Mark A, Chen, Jiu‐Chiuan, Weitlauf, Julie, Hayden, Kathleen M, Rapp, Stephen R, Resnick, Susan M, Garcia, Lorena, Cannell, Brad, Baker, Laura D, Sachs, Bonnie C, Tindle, Hilary A, Wallace, Robert, Casanova, Ramon, and Group, for the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study
- Subjects
Health Services and Systems ,Health Sciences ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Acquired Cognitive Impairment ,Dementia ,Alzheimer's Disease ,Brain Disorders ,Aging ,Behavioral and Social Science ,Prevention ,Clinical Research ,Neurodegenerative ,Neurosciences ,Good Health and Well Being ,Aged ,Aged ,80 and over ,Cognition ,Cohort Studies ,Female ,Follow-Up Studies ,Geriatric Assessment ,Humans ,Longitudinal Studies ,Mental Status and Dementia Tests ,Postmenopause ,Reproducibility of Results ,Time Factors ,global cognitive function ,longitudinal trajectories ,assessment modalities ,risk factors ,Women's Health Initiative Memory Study Magnetic Resonance Imaging Study Group ,Medical and Health Sciences ,Geriatrics ,Biomedical and clinical sciences ,Health sciences ,Psychology - Abstract
ObjectivesTo examine whether trajectories of global cognitive function over time in studies that change assessment protocols may be modeled based on an individual's performance relative to others in the study cohort.DesignExtended follow-up of a cohort originally enrolled in a clinical trial of postmenopausal hormone therapy.SettingThe Women's Health Initiative Memory Study switched from an in-person interview with the Modified Mini-Mental State Examination to a telephone-based interview with the modified Telephone Interview for Cognitive Status to assess global cognitive function over long-term follow-up.ParticipantsWomen aged 75 to 92 (N=2,561).MeasurementsAnnual cognitive assessments from participants, ranked according to age-, race- and ethnicity-adjusted performance levels, were used to identify distinct trajectories. Participants assigned to the resulting trajectories were compared for selected risk factor profiles.ResultsOur approach grouped participants into five trajectories according to relative cognitive performance over time. These groups differed significantly according to 3 known risk factors for cognitive decline-education level, apolipoprotein E-ϵ4 genotype, and type 2 diabetes mellitus-and a biomarker based on brain structure that has been linked to cognitive decline and Alzheimer's disease. Participants with consistently low relative levels of cognitive function over time and those whose relative performance over time declined to these levels tended to have poorer risk factor profiles.ConclusionLongitudinal measures of an individual's relative performance on different assessment protocols for global cognitive function can be used to identify trajectories of change over time that appear to have internal validity with respect to known risk factors.
- Published
- 2018
18. Cognitive Function and Changes in Cognitive Function as Predictors of Incident Cardiovascular Disease: The Women’s Health Initiative Memory Study
- Author
-
Leng, Xiaoyan, Espeland, Mark A, Manson, JoAnn E, Stefanick, Marcia L, Gower, Emily W, Hayden, Kathleen M, Limacher, Marian C, Vaughan, Leslie, Robinson, Jennifer, Wallace, Robert, Wassertheil-Smoller, Sylvia, Yaffe, Kristine, and Shumaker, Sally A
- Subjects
Heart Disease - Coronary Heart Disease ,Atherosclerosis ,Brain Disorders ,Cardiovascular ,Aging ,Heart Disease ,Aetiology ,2.4 Surveillance and distribution ,Stroke ,Good Health and Well Being ,Aged ,Cardiovascular Diseases ,Cause of Death ,Cognitive Dysfunction ,Female ,Humans ,Incidence ,Predictive Value of Tests ,Proportional Hazards Models ,Risk Assessment ,Risk Factors ,Surveys and Questionnaires ,United States ,Cognitive impairment ,Cognitive function decline ,CVD ,Mortality ,Clinical Sciences ,Gerontology - Abstract
BackgroundCognitive impairment and decline may signal the increased risk of incident cardiovascular disease (CVD). We examined associations of global cognitive function, as measured by the Modified Mini-Mental State Examination (3MS) and changes in 3MS over time, with incident CVD, individual CVD outcomes, CVD death, and all-cause mortality.MethodsA total of 5,596 women (≥ 60) from the Women's Health Initiative Memory Study free of CVD at baseline were followed for an average of 7.1 years. The 3MS was measured at baseline and annually thereafter. Cox proportional hazards regressions were used to model associations between baseline 3MS and changes in 3MS and time to events.ResultsIn the fully-adjusted models for every 5-point lower baseline 3MS score, the risk was 12% greater for incident CVD, 37% for HF, 35% for CVD death, and 24% for all-cause mortality. No significant relationships were found for coronary heart disease (CHD), angina, stroke/transient ischemic attack (TIA), or coronary revascularization. When change in 3MS was added as a time-varying covariate in the fully-adjusted models, for every 1-point/year greater decline in 3MS, the risk was 4% greater for incident CVD, 10% for CHD, 9% for Stroke/TIA, 17% for CVD death, and 13% for all-cause mortality.ConclusionsIn older women free of prevalent CVD at baseline, lower baseline global cognitive function or decline in global cognitive function over time, increased risk of incident CVD, CVD death, and all-cause mortality.
- Published
- 2018
19. Relationship of Lipids and Lipid-Lowering Medications With Cognitive Function: The Multi-Ethnic Study of Atherosclerosis.
- Author
-
Ong, Kwok Leung, Morris, Margaret J, McClelland, Robyn L, Hughes, Timothy M, Maniam, Jayanthi, Fitzpatrick, Annette L, Martin, Seth S, Luchsinger, José A, Rapp, Stephen R, Hayden, Kathleen M, Sandfort, Veit, Allison, Matthew A, and Rye, Kerry-Anne
- Subjects
Epidemiology ,Health Sciences ,Behavioral and Social Science ,Brain Disorders ,Prevention ,Cardiovascular ,Acquired Cognitive Impairment ,Aging ,Dementia ,Atherosclerosis ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Black or African American ,Asian ,China ,Cholesterol ,Cholesterol ,HDL ,Cholesterol ,LDL ,Cognition ,Cognition Disorders ,Female ,Hispanic or Latino ,Humans ,Hypolipidemic Agents ,Male ,Mental Status and Dementia Tests ,Racial Groups ,Risk Factors ,Triglycerides ,United States ,White People ,cholesterol ,cognitive decline ,cognitive function ,lipid-lowering medications ,lipids ,statins ,Mathematical Sciences ,Medical and Health Sciences - Abstract
Studies on the relationship of cholesterol concentrations and lipid-lowering medications with dementia risk have yielded inconsistent findings. Therefore, we investigated the association of lipid concentrations and lipid-lowering medications with cognitive function in the Multi-Ethnic Study of Atherosclerosis across 3 different cognitive domains assessed by means of the Cognitive Abilities Screening Instrument (CASI; version 2), the Digit Symbol Coding (DSC) Test, and the Digit Span (DS) Test in 2010-2012. After adjustment for sociodemographic and confounding factors, including concentrations of other lipids and use of lipid-lowering medication, higher total cholesterol, low-density lipoprotein cholesterol, and non-high-density-lipoprotein cholesterol concentrations were modestly associated with higher DS Test scores. None of the lipid parameters were associated with CASI or DSC Test scores. Similarly, changes in lipid concentrations were not associated with any cognitive function test score. Using treatment effects model analysis and after adjusting for confounding factors, including lipid concentrations, the use of any lipid-lowering medication, especially statins, was associated with higher scores on the CASI and backward DS tests but not on the DSC and forward DS tests. Our study does not support a robust association between lipid concentrations and cognitive function or between the use of lipid-lowering medication, especially statins, and worse cognitive function.
- Published
- 2018
20. Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study.
- Author
-
Corrada, María M, Hayden, Kathleen M, Paganini-Hill, Annlia, Bullain, Szofia S, DeMoss, Jaime, Aguirre, Colette, Brookmeyer, Ron, and Kawas, Claudia H
- Subjects
Humans ,Dementia ,Hypertension ,Antihypertensive Agents ,Severity of Illness Index ,Proportional Hazards Models ,Risk Factors ,Longitudinal Studies ,Follow-Up Studies ,Age of Onset ,Aged ,80 and over ,Female ,Male ,Self Report ,Surveys and Questionnaires ,Mental Status and Dementia Tests ,Blood pressure ,Epidemiology ,Oldest-old ,Risk factors ,Aging ,Neurodegenerative ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Brain Disorders ,Acquired Cognitive Impairment ,Alzheimer's Disease ,Clinical Research ,Cardiovascular ,Prevention ,2.4 Surveillance and distribution ,Neurological ,Geriatrics ,Clinical Sciences ,Neurosciences - Abstract
IntroductionWe investigated the association between age of onset of hypertension and dementia risk in an oldest-old cohort.MethodsParticipants are from The 90+ Study, a population-based longitudinal study of people aged 90+ who are survivors from the Leisure World Cohort Study. We estimated hypertension onset age using self-reported information from The 90+ Study and Leisure World Cohort Study, collected about 20 years earlier. A total of 559 participants without dementia were followed every 6 months for up to 10 years.ResultsA total of 224 participants developed dementia during follow-up (mean = 2.8 years). Compared with those without hypertension, participants whose hypertension onset age was 80 to 89 years had a lower dementia risk (hazard ratio = 0.58, P = .04) and participants with an onset age of 90+ years had the lowest risk (hazard ratio = 0.37, P = .004).DiscussionDeveloping hypertension at older ages may protect against dementia. Understanding the mechanisms for this lower risk is important for determining ways to prevent dementia in the very elderly.
- Published
- 2017
21. Systematic Review of Longitudinal Evidence and Methodologies for Research on Neighborhood Characteristics and Brain Health.
- Author
-
Michael, Yvonne L., Senerat, Araliya M., Buxbaum, Channa, Ezeanyagu, Ugonwa, Hughes, Timothy M., Hayden, Kathleen M., Langmuir, Julia, Besser, Lilah M., Sánchez, Brisa, and Hirsch, Jana A.
- Subjects
NEIGHBORHOOD characteristics ,ALZHEIMER'S disease ,RACE ,RESEARCH methodology ,DEVELOPED countries - Abstract
Objective: Synthesize longitudinal research evaluating neighborhood environments and cognition to identify methodological approaches, findings, and gaps. Methods: Included studies evaluated associations between neighborhood and cognition longitudinally among adults >45 years (or mean age of 65 years) living in developed nations. We extracted data on sample characteristics, exposures, outcomes, methods, overall findings, and assessment of disparities. Results: Forty studies met our inclusion criteria. Most (65%) measured exposure only once and a majority focused on green space and/or blue space (water), neighborhood socioeconomic status, and recreation/physical activity facilities. Similarly, over half studied incident impairment, cognitive function or decline (70%), with one examining MRI (2.5%) or Alzheimer's disease (7.5%). While most studies used repeated measures analysis to evaluate changes in the brain health outcome (51%), many studies did not account for any type of correlation within neighborhoods (35%). Less than half evaluated effect modification by race/ethnicity, socioeconomic status, and/or sex/gender. Evidence was mixed and dependent on exposure or outcome assessed. Conclusion: Although longitudinal research evaluating neighborhood and cognitive decline has expanded, gaps remain in types of exposures, outcomes, analytic approaches, and sample diversity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Hearing loss and cognition: A protocol for ensuring speech understanding before neurocognitive assessment.
- Author
-
Kolberg, Elizabeth R., Morales, Emmanuel E. Garcia, Thallmayer, Tara W., Arnold, Michelle L., Burgard, Sheila, Chisolm, Theresa H., Coresh, Josef, Couper, David, Hayden, Kathleen M., Huang, Alison R., Lin, Frank R., Mitchell, Christine M., Mosley, Thomas H., Gravens‐Mueller, Lisa, Owens, Tiffany A., Pankow, James S., Pike, James Russell, Reed, Nicholas S., Sanchez, Victoria, and Schrack, Jennifer A.
- Abstract
INTRODUCTION: Many neurocognitive evaluations involve auditory stimuli, yet there are no standard testing guidelines for individuals with hearing loss. The ensuring speech understanding (ESU) test was developed to confirm speech understanding and determine whether hearing accommodations are necessary for neurocognitive testing. METHODS: Hearing was assessed using audiometry. The probability of ESU test failure by hearing status was estimated in 2679 participants (mean age: 81.4 ± 4.6 years) using multivariate logistic regression. RESULTS: Only 2.2% (N = 58) of participants failed the ESU test. The probability of failure increased with hearing loss severity; similar results were observed for those with and without mild cognitive impairment or dementia. DISCUSSION: The ESU test is appropriate for individuals who have variable degrees of hearing loss and cognitive function. This test can be used prior to neurocognitive testing to help reduce the risk of hearing loss and compromised auditory access to speech stimuli causing poorer performance on neurocognitive evaluation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Description of the Baseline Audiologic Characteristics of the Participants Enrolled in the Aging and Cognitive Health Evaluation in Elders Study.
- Author
-
Sanchez, Victoria A., Arnold, Michelle L., Betz, Joshua F., Reed, Nicholas S., Faucette, Sarah, Anderson, Elizabeth, Burgard, Sheila, Coresh, Josef, Deal, Jennifer A., Eddins, Ann Clock, Goman, Adele M., Glynn, Nancy W., Gravens-Mueller, Lisa, Hampton, Jaime, Hayden, Kathleen M., Huang, Alison R., Liou, Kaila, Mitchell, Christine M., Mosley Jr., Thomas H., and Neil, Haley N.
- Subjects
MIDDLE ear physiology ,COGNITION disorder risk factors ,HEALTH education ,KRUSKAL-Wallis Test ,STATISTICS ,HEARING impaired ,SPEECH audiometry ,SELF-evaluation ,SENSORINEURAL hearing loss ,OTOSCOPY ,IMPEDANCE audiometry ,RISK assessment ,AGING ,INDEPENDENT living ,AUDIOMETRY ,DESCRIPTIVE statistics ,CHI-squared test ,REHABILITATION ,DATA analysis ,DATA analysis software ,SECONDARY analysis ,DISEASE complications ,OLD age - Abstract
Purpose: The Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study is a randomized clinical trial designed to determine the effects of a bestpractice hearing intervention versus a successful aging health education control intervention on cognitive decline among community-dwelling older adults with untreated mild-to-moderate hearing loss. We describe the baseline audiologic characteristics of the ACHIEVE participants. Method: Participants aged 70-84 years (N = 977; M
age = 76.8) were enrolled at four U.S. sites through two recruitment routes: (a) an ongoing longitudinal study and (b) de novo through the community. Participants underwent diagnostic evaluation including otoscopy, tympanometry, pure-tone and speech audiometry, speech-in-noise testing, and provided self-reported hearing abilities. Baseline characteristics are reported as frequencies (percentages) for categorical variables or medians (interquartiles, Q1-Q3) for continuous variables. Between-groups comparisons were conducted using chi-square tests for categorical variables or Kruskal--Wallis test for continuous variables. Spearman correlations assessed relationships between measured hearing function and self-reported hearing handicap. Results: The median four-frequency pure-tone average of the better ear was 39 dB HL, and the median speech-in-noise performance was a 6-dB SNR loss, indicating mild speech-in-noise difficulty. No clinically meaningful differences were found across sites. Significant differences in subjective measures were found for recruitment route. Expected correlations between hearing measurements and self-reported handicap were found. Conclusions: The extensive baseline audiologic characteristics reported here will inform future analyses examining associations between hearing loss and cognitive decline. The final ACHIEVE data set will be publicly available for use among the scientific community. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
24. Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia
- Author
-
Chatterjee, Saion, Peters, Sanne AE, Woodward, Mark, Arango, Silvia Mejia, Batty, G David, Beckett, Nigel, Beiser, Alexa, Borenstein, Amy R, Crane, Paul K, Haan, Mary, Hassing, Linda B, Hayden, Kathleen M, Kiyohara, Yutaka, Larson, Eric B, Li, Chung-Yi, Ninomiya, Toshiharu, Ohara, Tomoyuki, Peters, Ruth, Russ, Tom C, Seshadri, Sudha, Strand, Bjørn H, Walker, Rod, Xu, Weili, and Huxley, Rachel R
- Subjects
Dementia ,Clinical Research ,Neurosciences ,Diabetes ,Aging ,Acquired Cognitive Impairment ,Prevention ,Brain Disorders ,Metabolic and endocrine ,Aged ,Aged ,80 and over ,Dementia ,Vascular ,Diabetes Mellitus ,Type 2 ,Female ,Humans ,Male ,Middle Aged ,Prospective Studies ,Risk Factors ,Sex Factors - Abstract
ObjectiveType 2 diabetes confers a greater excess risk of cardiovascular disease in women than in men. Diabetes is also a risk factor for dementia, but whether the association is similar in women and men remains unknown. We performed a meta-analysis of unpublished data to estimate the sex-specific relationship between women and men with diabetes with incident dementia.Research design and methodsA systematic search identified studies published prior to November 2014 that had reported on the prospective association between diabetes and dementia. Study authors contributed unpublished sex-specific relative risks (RRs) and 95% CIs on the association between diabetes and all dementia and its subtypes. Sex-specific RRs and the women-to-men ratio of RRs (RRRs) were pooled using random-effects meta-analyses.ResultsStudy-level data from 14 studies, 2,310,330 individuals, and 102,174 dementia case patients were included. In multiple-adjusted analyses, diabetes was associated with a 60% increased risk of any dementia in both sexes (women: pooled RR 1.62 [95% CI 1.45-1.80]; men: pooled RR 1.58 [95% CI 1.38-1.81]). The diabetes-associated RRs for vascular dementia were 2.34 (95% CI 1.86-2.94) in women and 1.73 (95% CI 1.61-1.85) in men, and for nonvascular dementia, the RRs were 1.53 (95% CI 1.35-1.73) in women and 1.49 (95% CI 1.31-1.69) in men. Overall, women with diabetes had a 19% greater risk for the development of vascular dementia than men (multiple-adjusted RRR 1.19 [95% CI 1.08-1.30]; P < 0.001).ConclusionsIndividuals with type 2 diabetes are at ∼60% greater risk for the development of dementia compared with those without diabetes. For vascular dementia, but not for nonvascular dementia, the additional risk is greater in women.
- Published
- 2016
25. Visit-to-Visit Glucose Variability, Cognition, and Global Cognitive Decline: The Multi-Ethnic Study of Atherosclerosis.
- Author
-
Schaich, Christopher L, Bancks, Michael P, Hayden, Kathleen M, Ding, Jingzhong, Rapp, Stephen R, Bertoni, Alain G, Heckbert, Susan R, Hughes, Timothy M, and Mongraw-Chaffin, Morgana
- Subjects
GLUCOSE analysis ,ATHEROSCLEROSIS ,TYPE 2 diabetes diagnosis - Abstract
Context Higher visit-to-visit glucose variability (GV) is associated with dysglycemia and type 2 diabetes (T2D), key risk factors for cognitive decline. Objective Evaluate the association of GV with cognitive performance and decline in racially/ethnically diverse older populations with and without T2D. Methods We calculated the standard deviation of glucose (SDG), average real variability (ARV), and variability independent of the mean (VIM) among 4367 Multi-Ethnic Study of Atherosclerosis participants over 6 clinical examinations. Participants completed a cognitive assessment at the fifth examination, and a subset completed a second assessment 6 years later. We used multivariable linear regression to estimate the association of intraindividual GV with cognitive test scores after adjustments for cardiovascular risk factors and mean glucose level over the study period. Results Two-fold increments in the VIM and SDG were associated with worse Cognitive Abilities Screening Instrument (CASI) performance, while two-fold increments in VIM and ARV were associated with worse Digit Symbol Coding test score. GV measures were not associated with change in CASI performance among 1834 participants with repeat CASI data 6 years later. However, among 229 participants with incident T2D, the SDG and VIM were associated with decline in CASI (−1.7 [95% CI: −3.1, −0.3] and −2.1 [−3.7, −0.5] points, respectively). In contrast, single-timepoint glucose and HbA1c were not associated with CASI decline among participants with or without incident T2D. Conclusion Higher visit-to-visit GV over 16 to 18 years is associated with worse cognitive performance in the general population, and with modest global cognitive decline in participants with T2D. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Rationale, design, and cohort characteristics of the Action for Health in Diabetes Aging study.
- Author
-
Espeland, Mark A., Houston, Denise K., Hayden, Kathleen M., Bahnson, Judy L., Huckfeldt, Peter J., Chen, Haiying, Walkup, Michael P., Neiberg, Rebecca H., Yang, Mia, Beckner, Tara, and Wagenknecht, Lynne E.
- Subjects
GERIATRIC psychiatry ,OLDER people ,AGING ,MEDICAL care use ,TYPE 2 diabetes ,QUALITY of life ,CARDIOVASCULAR diseases ,OBESITY - Abstract
INTRODUCTION: Diabetes and overweight/obesity are described as accelerating aging processes, yet many individuals with these conditions maintain high levels of cognitive and physical function and independence late into life. The Look AHEAD Aging study is designed to identify 20‐year trajectories of behaviors, risk factors, and medical history associated with resilience against geriatric syndromes and aging‐related cognitive and physical functional deficits among individuals with these conditions. METHODS: Look AHEAD Aging extends follow‐up of the cohort of the former 10‐year Look AHEAD trial. The original cohort (N = 5145) was enrolled in 2001 to 2004 when participants were aged 45 to 76 years and randomly assigned to a multidomain intensive lifestyle intervention (ILI) or a diabetes support and education (DSE) condition. The trial interventions ceased in 2012. Clinic‐based follow‐up continued through 2020. In 2021, the cohort was invited to enroll in Look AHEAD Aging, an additional 4‐year telephone‐based follow‐up (every 6 months) enhanced with Medicare linkage. Standardized protocols assess multimorbidity, physical and cognitive function, health care utilization, and health‐related quality of life. RESULTS: Of the original N = 5145 Look AHEAD participants, N = 1552 active survivors agreed to participate in Look AHEAD Aging. At consent, the cohort's mean age was 76 (range 63 to 94) years and participants had been followed for a mean of 20 years. Of the original Look AHEAD enrollees, those who were younger, female, or with no history of cardiovascular disease were more likely to be represented in the Look AHEAD Aging cohort. Intervention groups were comparable with respect to age, diabetes duration, body mass index, insulin use, hypertension, cardiovascular disease, and cognitive function. ILI participants had significantly lower deficit accumulation index scores. DISCUSSION: By continuing the long‐term follow‐up of an extensively characterized cohort of older individuals with type 2 diabetes, Look AHEAD Aging is well positioned to identify factors associated with resilience against aging‐related conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. Accelerometer‐measured physical activity and sitting with incident mild cognitive impairment or probable dementia among older women.
- Author
-
Nguyen, Steve, LaCroix, Andrea Z., Hayden, Kathleen M., Di, Chongzhi, Palta, Priya, Stefanick, Marcia L., Manson, JoAnn E., Rapp, Stephen R., LaMonte, Michael J., and Bellettiere, John
- Abstract
Introduction: Physical activity (PA) is prospectively inversely associated with dementia risk, but few studies examined accelerometer measures of PA and sitting with rigorously‐adjudicated mild cognitive impairment (MCI) and dementia risk. Methods: We examined the associations of accelerometer measures (PA and sitting) with incident MCI/probable dementia in the Women's Health Initiative (n = 1277; mean age = 82 ± 6 years) Results: Over a median follow‐up of 4.2 years, 267 MCI/probable dementia cases were identified. Adjusted Cox regression HRs (95% CI) across moderate‐to‐vigorous PA (MVPA) min/d quartiles were 1.00 (reference), 1.28 (0.90 to 1.81), 0.79 (0.53 to 1.17), and 0.69 (0.45 to 1.06); P‐trend = 0.01. Adjusted HRs (95% CI) across steps/d quartiles were 1.00 (reference), 0.73 (0.51 to 1.03), 0.64 (0.43 to 0.94), and 0.38 (0.23 to 0.61); P‐trend < 0.001. The HR (95% CI) for each 1‐SD increment in MVPA (31 min/d) and steps/d (1865) were 0.79 (0.67 to 0.94) and 0.67 (0.54 to 0.82), respectively. Sitting was not associated with MCI/probable dementia. Discussion: Findings suggest ≥ moderate intensity PA, particularly stepping, associates with lower MCI and dementia risk. Highlights: Few studies have examined accelerometer‐measured physical activity, including steps, and sitting with incident ADRD.Moderate‐to‐vigorous physical activity and steps, but not light physical activity or sitting, were inversely associated with lower ADRD risk.Among older women, at least moderate intensity physical activity may be needed to reduce ADRD risk. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
28. Predictors of cognitive and physical decline: Results from the Health Aging and Body Composition Study.
- Author
-
Handing, Elizabeth P., Hayden, Kathleen M., Xiaoyan Iris Leng, and Kritchevsky, Stephen B.
- Subjects
COGNITION disorder risk factors ,BODY composition ,ACTIVE aging ,CONFIDENCE intervals ,FUNCTIONAL status ,MULTIPLE regression analysis ,RISK assessment ,NEUROPSYCHOLOGICAL tests ,BODY movement ,REPEATED measures design ,DESCRIPTIVE statistics ,RESEARCH funding ,ODDS ratio ,LONGITUDINAL method - Abstract
Background: Risk factors for cognitive decline and physical decline have been studied independently, however older adults might experience decline in both areas i.e., dual decline. Risk factors associated with dual decline are largely unknown and have significant implications on health outcomes. The aim of this study is to explore risk factors associated with dual decline. Methods: Using data from the Health, Aging and Body Composition (Health ABC) study, a longitudinal prospective cohort study, we examined trajectories of decline based on repeated measures of the Modified Mini-Mental State Exam (3MSE) and the Short Physical Performance Battery (SPPB) across 6 years (n=1,552). We calculated four mutually exclusive trajectories of decline and explored predictors of decline: cognitive decline (n = 306) = lowest quartile of slope on the 3MSE or 1.5 SD below mean at baseline, physical decline (n = 231) = lowest quartile of slope on the SPPB or 1.5 SD below mean at baseline, dual decline (n = 110) = lowest quartile in both measures or 1.5 SD below mean in both measures at baseline. Individuals who did not meet criteria for one of the decline groups were classified as the reference group. (n= 905). Results: Multinomial logistic regression tested the association of 17 baseline risk factors with decline. Odds of dual decline where significantly higher for individuals at baseline with depressive symptoms (CES-D >16) (Odds Ratio (OR)=2.49, 95% Confidence Interval (CI): 1.05-6.29), ApoE-e4 carrier (OR= 2.09, 95% CI: 1.06-1.95), or if individuals had lost 5+lbs in past year (OR=1.79, 95% CI: 1.13-2.84). Odds were significantly lower for individuals with a higher score on the Digit Symbol Substitution Test per standard deviation (OR per SD: 0.47, 95% CI 0.36-0.62) and faster 400-meter gait (OR per SD= 0.49, 95% CI: 0.37-0.64). Conclusion: Among predictors, depressive symptoms at baseline significantly increased the odds of developing dual decline but was not associated with decline in the exclusively cognitive or physical decline groups. APOE-e4 status increased the odds for cognitive decline and dual decline but not physical decline. More research on dual decline is needed because this group represents a high risk, vulnerable subset of older adults. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. Gradient and Acceleration of Decline in Physical and Cognitive Functions in Older Adults: A Disparity Analysis.
- Author
-
Ip, Edward H, Chen, Shyh-Huei, Rejeski, W Jack, Bandeen-Roche, Karen, Hayden, Kathleen M, Hugenschmidt, Christina E, Pierce, June, Miller, Michael E, Speiser, Jaime L, Kritchevsky, Stephen B, Houston, Denise K, Newton, Robert L, Rapp, Stephen R, and Kitzman, Dalane W
- Subjects
MOTION ,GAIT in humans ,CROSS-sectional method ,COGNITION ,PSYCHOLOGICAL tests ,RESEARCH funding - Abstract
Background: Substantive previous work has shown that both gait speed and global cognition decline as people age. Rates of their decline, as opposed to cross-sectional measurements, could be more informative of future functional status and other clinical outcomes because they more accurately represent deteriorating systems. Additionally, understanding the sex and racial disparity in the speed of deterioration, if any, is also important as ethnic minorities are at an increased risk of mobility disability and dementia.Method: Data from 2 large longitudinal intervention studies were integrated. Rates of decline were derived from individual-level measures of gait speed of 400-m walk and scores on the Modified Mini Mental State Examination (3MSE). We also assessed age-associated declines and accelerations in changes across the ages represented in the studies (age range 53-90).Results: The mean rate of decline in 400-m gait speed across individuals was 0.03 m/s per year, and multivariable analysis showed a significant acceleration in decline of -0.0013 m/s/y2 (p < .001). Both race and sex moderated the rate of decline. For global cognition, the mean rate of decline was 0.05 of a point per year on the 3MSE scale, and acceleration in the rate of decline was significant (-0.017 point/y2, p < .001), but neither sex nor race moderated the decline.Conclusion: Rate of decline in physical but not cognitive function appears moderated by sex and race. This finding, as well as rates and accelerations of decline estimated herein, could inform future intervention studies.Clinical Trials Registration Number: NCT00017953 (Look AHEAD); NCT01410097 (Look AHEAD ancillary); NCT00116194 (LIFE). [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
30. Eight-Year Changes in Multimorbidity and Frailty in Adults With Type 2 Diabetes Mellitus: Associations With Cognitive and Physical Function and Mortality.
- Author
-
Espeland, Mark A, Justice, Jamie Nicole, Bahnson, Judy, Evans, Joni K, Munshi, Medha, Hayden, Kathleen M, Simpson, Felicia R, Johnson, Karen C, Johnston, Craig, Kritchevsky, Stephen R, and Look AHEAD Research Group
- Subjects
COGNITION ,TYPE 2 diabetes ,RESEARCH funding ,DISEASE complications - Abstract
Background: Indices of multimorbidity and deficit accumulation (ie, frailty indices) have been proposed as markers of biological aging. If true, changes in these indices over time should predict downstream changes in cognition and physical function, and mortality.Methods: We examined associations that 8-year changes in (i) a multimorbidity index comprised of 9 chronic diseases and (ii) a frailty index (FI) based on deficit accumulation in functional, behavioral, and clinical characteristics had with subsequent measures of cognitive and physical function over 10 years. We drew data from 3 842 participants in the Action for Health in Diabetes clinical trial. They were aged 45-76 years at baseline and at risk for accelerated biological aging due to overweight/obesity and type 2 diabetes mellitus.Results: A total of 1 501 (39%) of the cohort had 8-year increases of 1 among the 9 diseases tracked in the multimorbidity index and 868 (23%) had increases of ≥2. Those with greatest increases in multimorbidity tended to be older individuals, males, and non-Hispanic Whites. Greater FI increases tended to occur among individuals who were older, non-Hispanic White, heavier, and who had more baseline morbidities. Changes in multimorbidity and FI were moderately correlated (r = 0.26; p < .001). Increases in both multimorbidity and FI were associated with subsequently poorer composite cognitive function and 400-m walk speed and increased risk for death (all p < .001).Conclusions: Accelerated biological aging, as captured by multimorbidity and frailty indices, predicts subsequent reduced function and mortality. Whether intensive lifestyle interventions generally targeting multimorbidity and FI reduce risks for downstream outcomes remains to be seen. Clinical Trials Registration Number: NCT00017953. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
31. Associations among vascular risk factors, neuroimaging biomarkers, and cognition: Preliminary analyses from the Multi‐Ethnic Study of Atherosclerosis (MESA).
- Author
-
Lockhart, Samuel N., Schaich, Christopher L., Craft, Suzanne, Sachs, Bonnie C., Rapp, Stephen R., Jung, Youngkyoo, Whitlow, Christopher T., Solingapuram Sai, Kiran Kumar, Cleveland, Maryjo, Williams, Benjamin J., Burke, Gregory L., Bertoni, Alain, Hayden, Kathleen M., and Hughes, Timothy M.
- Abstract
Introduction: Little is known about how antecedent vascular risk factor (VRF) profiles impact late‐life brain health. Methods: We examined baseline VRFs, and cognitive testing and neuroimaging measures (β‐amyloid [Aβ] PET, MRI) in a diverse longitudinal cohort (N = 159; 50% African‐American, 50% White) from Wake Forest's Multi‐Ethnic Study of Atherosclerosis Core. Results: African‐Americans exhibited greater baseline Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE), Framingham stroke risk profile (FSRP), and atherosclerotic cardiovascular disease risk estimate (ASCVD) scores than Whites. We observed no significant racial differences in Aβ positivity, cortical thickness, or white matter hyperintensity (WMH) volume. Higher baseline VRF scores were associated with lower cortical thickness and greater WMH volume, and FSRP and CAIDE were associated with Aβ. Aβ was cross‐sectionally associated with cognition, and all imaging biomarkers were associated with greater 6‐year cognitive decline. Discussion: Results suggest the convergence of multiple vascular and Alzheimer's processes underlying neurodegeneration and cognitive decline. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
32. The American Geriatrics Society/National Institute on Aging Bedside-to-Bench Conference: Research Agenda on Delirium in Older Adults.
- Author
-
Alessi, Cathy, Auerbach, Andrew, Avelino‐Silva, Thiago J., Boustani, Malaz, Brown, Emery, Brummel, Nathan E., Campbell, Noll, Cunningham, Colm, Davis, Daniel, Deiner, Stacie, Dugan, Laura, Eldadah, Basil, Wesley Ely, E., Fick, Donna, Gould, Robert, Hansen, Jennie Chin, Han, Jin Ho, Hayden, Kathleen M., Hopkins, Ramona O., and Hughes, Christopher G.
- Subjects
DELIRIUM ,AGING ,DIAGNOSIS of delirium ,RISK of delirium ,BIOMARKERS ,COGNITION ,DEMENTIA ,SYNDROMES ,COMORBIDITY ,CONFERENCES & conventions ,PREVENTION - Abstract
The article discusses the conference "Delirium in Older Adults: Finding Order in the Disorder" held by the American Geriatrics Society in conjunction with the U.S. National Institute on Aging and the John A. Hartford Foundation on February 9-11, 2014. Topics include the relationship between delirium and other geriatric conditions, biomarkers of delirium, and treatments.
- Published
- 2015
- Full Text
- View/download PDF
33. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging.
- Author
-
Hayden, Kathleen M., McEvoy, Jill M., Linnertz, Colton, Attix, Deborah, Kuchibhatla, Maragatha, Saunders, Ann M., Lutz, Michael W., Welsh-Bohmer, Kathleen A., Roses, Allen D., and Chiba-Falek, Ornit
- Subjects
GENETIC polymorphisms ,COGNITIVE ability ,AGING ,ALZHEIMER'S disease ,QUESTIONNAIRES ,NEUROPSYCHOLOGICAL tests - Abstract
Abstract: Introduction: A highly polymorphic T homopolymer was recently found to be associated with late-onset Alzheimer’s disease risk and age of onset. Objective: To explore the effects of the polymorphic polyT tract (rs10524523, referred as ‘523’) on cognitive performance in cognitively healthy elderly individuals. Methods: One hundred eighty-one participants were recruited from local independent-living retirement communities. Informed consent was obtained, and participants completed demographic questionnaires, a conventional paper-and-pencil neuropsychological battery, and the computerized Cambridge Neuropsychological Test Automated Battery (CANTAB). Saliva samples were collected for determination of the TOMM40 ‘523’ (S, L, VL) and the apolipoprotein E (APOE) (ɛ2, 3, 4) genotypes. From the initial sample of 181 individuals, 127 were eligible for the association analysis. Participants were divided into three groups based on ‘523’ genotypes (S/S, S/L-S/VL, and L/L-L/VL-VL/VL). Generalized linear models were used to evaluate the association between the ‘523’ genotypes and neuropsychological test performance. Analyses were adjusted for age, sex, education, depression, and APOE ɛ4 status. A planned subanalysis was undertaken to evaluate the association between ‘523’ genotypes and test performance in a sample restricted to APOE ɛ3 homozygotes. Results: The S homozygotes performed better, although not significantly, than the S/L-S/VL and the VL/L-L/VL-VL/VL genotype groups on measures associated with memory (CANTAB Paired Associates Learning, Verbal Recognition Memory free recall) and executive function (CANTAB measures of Intra-Extra Dimensional Set Shift). Follow-up analysis of APOE ɛ3 homozygotes only showed that the S/S group performed significantly better than the S/VL group on measures of episodic memory (CANTAB Paired Associates Learning and Verbal Recognition Memory free recall), attention (CANTAB Rapid Visual Information Processing latency), and executive function (Digit Symbol Substitution). The S/S group performed marginally better than the VL/VL group on Intra-Extra Dimensional Set Shift. None of the associations remained significant after applying a Bonferroni correction for multiple testing. Conclusions: Results suggest important APOE-independent associations between the TOMM40 ‘523’ polymorphism and specific cognitive domains of memory and executive control that are preferentially affected in early-stage Alzheimer’s disease. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
34. [image omitted]Neuropsychological performance in advanced age: Influences of Demographic factors and Apolipoprotein E: Findings from the Cache County Memory Study.
- Author
-
Welsh-Bohmer, Katheen A., Østbye, Truls, Sanders, Linda, Pieper, Carl F., Hayden, Kathleen M., Tschanz, JoAnn T., and Norton, Maria C.
- Subjects
NEUROPSYCHOLOGICAL tests ,ALZHEIMER'S disease ,EPIDEMIOLOGICAL research ,DISEASES in older people ,DEMENTIA ,RESEARCH - Abstract
The Cache County Study of Memory in Aging (CCMS) is an epidemiological study of Alzheimer's disease (AD), mild cognitive disorders, and aging in a population of exceptionally long-lived individuals (7th to 11th decade). Observation of population members without dementia provides an opportunity for establishing the range of normal neurocognitive performance in a representative sample of the very old. We examined neurocognitive performance of the normal participants undergoing full clinical evaluations (n = 507) and we tested the potential modifying effects of apolipoprotein E (APOE) genotype, a known genetic risk factor for the later development of AD. The results indicate that advanced age and low education are related to lower test scores across nearly all of the neurocognitive measures. Gender and APOE ε4 both had negligible and inconsistent influences, affecting only isolated measures of memory and expressive speech (in case of gender). The gender and APOE effects disappeared once age and education were controlled. The study of this exceptionally long-lived population provides useful normative information regarding the broad range of “normal” cognition seen in advanced age. Among elderly without dementia or other cognitive impairment, APOE does not appear to exert any major effects on cognition once other demographic influences are controlled. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
35. Modifying dementia risk and trajectories of cognitive decline in aging: The Cache County Memory Study.
- Author
-
Welsh-Bohmer, Kathleen A., Breitner, John C.S., Hayden, Kathleen M., Lyketsos, Constantine, Zandi, Peter P., Tschanz, JoAnn T., Norton, Maria C., and Munger, Ron
- Subjects
DEMENTIA ,AGING ,COGNITION disorders ,PSYCHOSES - Abstract
Abstract: The Cache County Study of Memory, Health, and Aging, more commonly referred to as the “Cache County Memory Study (CCMS)” is a longitudinal investigation of aging and Alzheimer’s disease (AD) based in an exceptionally long-lived population residing in northern Utah. The study begun in 1994 has followed an initial cohort of 5,092 older individuals (many over age 84) and has examined the development of cognitive impairment and dementia in relation to genetic and environmental antecedents. This article summarizes the major contributions of the CCMS towards the understanding of mild cognitive disorders and AD across the lifespan, underscoring the role of common health exposures in modifying dementia risk and trajectories of cognitive change. The study now in its fourth wave of ascertainment illustrates the role of population-based approaches in informing testable models of cognitive aging and Alzheimer’s disease. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
36. Does the impact of intensive lifestyle intervention on cognitive function vary depending baseline level of frailty? An ancillary study to the Action for Health in Diabetes (Look AHEAD) Trial.
- Author
-
Simpson, Felicia R., Carmichael, Owen, Hayden, Kathleen M., Hugenschmidt, Christina E., McCaffery, Jeanne M., Yasar, Sevil, Pajewski, Nicholas M., Espeland, Mark A., and Indices for Accelerated Aging in Obesity and Diabetes Ancillary Study of the Action for Health in Diabetes (Look AHEAD) Trial
- Subjects
- *
OBESITY complications , *OBESITY treatment , *LIFESTYLES , *COGNITION , *TYPE 2 diabetes , *WEIGHT loss , *DISEASE complications - Abstract
Aims: To assess whether there is an opportune window when intensive lifestyle intervention (ILI) benefits cognitive function.Methods: Standardized cognitive assessments were collected following ≥8 years of either ILI or a control condition of diabetes support and education (DSE) in 3708 individuals, ages 45-76 years at enrollment, with type 2 diabetes and overweight or obesity. Frailty index (FI) scores were used to group individuals at baseline into tertiles according to their age-related health status. Linear models were used to describe intervention adherence and cognitive function, with interaction terms to examine the consistency of relationships among tertiles.Results: Worse baseline FI scores were associated with poorer subsequent performance in tests of attention, processing speed, and executive function. No differences in any measure of cognitive function were observed between intervention groups within any FI tertile (all p > 0.10). Among individuals with worse baseline FI scores, weight gain was associated with poorer global cognitive function among participants assigned to DSE. There was no association between weight changes and cognitive function among participants assigned to ILI.Conclusions: Among adults with type 2 diabetes and overweight/obesity, we found no evidence that there is a window of opportunity based on FI when ILI benefits cognitive function. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.